Oct 26, 2022 / 11:00PM GMT
Erica Monaco - Biofrontera Inc. - CEO
Thank you, guys, for joining us this afternoon. I will keep it quick, so we have plenty of time for Q&A. Is that a problem. Okay. Just some forward-looking statements and disclaimers that we need to put in there.
Just to give you a quick background about the company. We are in the dermatology space. We are biopharma. We were founded in 2015.
We're located just north of Boston. We are commercial stage. We've been revenue-generating since we launched in the US in 2016.
The leadership team is comprised of myself; Mark Baldyga is our VP of Sales and Marketing; and Professor Hermann Luebbert, he's our Executive Chairman and the Founder of the company. And we recently appointed a CFO earlier this week, Fred, will be added to the deck shortly.
So we have two branded products in the market. They're FDA-approved prescription products in the dermatology space. But I'm going to spend most time talking to you today about our flagship product, Ameluz. It's Ameluz in conjunction with our BF-RhodoLED treatment of actinic keratosis. It's a
Biofrontera Inc at LD Micro Main Event Transcript
Oct 27, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers